ESRRA and breast carcinoma: We and others have previously determined that ERRα expression is higher in TNBC and contributes to its pathogenicity.3,18 While ERα-positive breast cancers can be treated with endocrine therapy, TNBC is treated with standard chemotherapy due to lack of FDA-approved targeted therapy options.